Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Sentinel Lymph Node Biopsy in BRCA1/2 Germline Pathogenic Variant Carriers Undergoing Risk-Reducing Mastectomy

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hunt KK, Euhus DM, Boughey JC, et al. Society of surgical oncology breast disease working group statement on prophylactic (Risk-Reducing) mastectomy. Ann Surg Oncol. 2017;24:375–97.

    Article  Google Scholar 

  2. Camara S, Pereira D, Andre S, et al. The use of sentinel lymph node biopsy in BRCA1/2 mutation carriers undergoing prophylactic mastectomy: a retrospective consecutive case-series study. Int J Breast Cancer. 2018;2018:1426369.

    Article  Google Scholar 

  3. Yamauchi H, Okawa M, Yokoyama S, et al. High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan. Breast Cancer Res Treat. 2018;172:679–87.

    Article  Google Scholar 

  4. Wong SMF, Apostolova C, Alhassan B, Prakash I, Basik M, Boileau JF, Meterissian S, Aleynikova O, Wong N, Foulkes WD. Incidence of occult breast cancer in carriers of BRCA1/2 or other high-penetrance pathogenic variants undergoing prophylactic mastectomy: when is sentinel lymph node biopsy indicated? Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11916-3.

    Article  PubMed  Google Scholar 

  5. Karakatsanis A, Hersi AF, Pistiolis L, et al. Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study). Br J Surg. 2019;106:720–8.

    Article  CAS  Google Scholar 

Download references

Funding

Fonds de Recherche du Québec – Santé (Grant Number 309854).

Author information

Authors and Affiliations

  1. Department of Surgery, McGill University Medical School, Montreal, QC, Canada

    Amina Ferroum MD(c) & Stephanie M. Wong MD, MPH

  2. Jewish General Hospital Stroll Cancer Prevention Centre, Segal Cancer Centre, Montreal, QC, Canada

    Amina Ferroum MD(c) & Stephanie M. Wong MD, MPH

  3. Department of Oncology, McGill University Medical School, Montreal, QC, Canada

    Stephanie M. Wong MD, MPH

Authors
  1. Amina Ferroum MD(c)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie M. Wong MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephanie M. Wong MD, MPH.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ferroum, A., Wong, S.M. ASO Author Reflections: Sentinel Lymph Node Biopsy in BRCA1/2 Germline Pathogenic Variant Carriers Undergoing Risk-Reducing Mastectomy. Ann Surg Oncol 29, 6669–6670 (2022). https://doi.org/10.1245/s10434-022-12013-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12013-1

Search

Navigation